Q2 2022 Holdings
Filed 2022-08-15 | 111 holdings | $379.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $99.2M | 5,321,032 | 26.2% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $68.2M | 3,540,408 | 18.0% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $39.5M | 9,903,879 | 10.4% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $27.9M | 3,088,972 | 7.4% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $26.4M | 3,645,471 | 7.0% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $25.2M | 172,991 | 6.7% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $22.8M | 11,521,102 | 6.0% |
| Artivion Inc(AORT) | COM | 228903100 | $17.6M | 929,705 | 4.6% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $15.4M | 1,697,033 | 4.1% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $14.9M | 180,000 | 3.9% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $5.8M | 766,231 | 1.5% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $4.8M | 341,239 | 1.3% |
| Clover Health Investments Co(CLOV) | COM CL A | 18914F103 | $3.2M | 1,500,000 | 0.8% |
| Absci Corporation(ABSI) | COM | 00091E109 | $3.0M | 894,346 | 0.8% |
| Acumen Pharmaceuticals Inc(ABOS) | COM | 00509G209 | $2.4M | 508,532 | 0.6% |
| Travere Therapeutics Inc | NOTE 2.250% 3/0 | 89422GAA5 | $455.9K | $45,000,000 | 0.1% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $288.9K | 26,895,532 | 0.1% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $192.5K | 2,866,863 | 0.1% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $134.5K | 5,086,727 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $130.6K | 11,826,299 | 0.0% |
| Lianbio | SPONSORED ADS | 53000N108 | $122.2K | 56,560,211 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $96.3K | 3,015,054 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $95.2K | 3,867,446 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $64.6K | 2,122,535 | 0.0% |
| Meiragtx Hldgs PLC(MGTX) | COM | G59665102 | $52.7K | 6,963,277 | 0.0% |
| Lyra Therapeutics Inc(LYRA) | COM | 55234L105 | $51.7K | 9,146,730 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $51.1K | 5,534,169 | 0.0% |
| Prometheus Biosciences Inc | COM | 74349U108 | $47.5K | 1,682,242 | 0.0% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $46.9K | 2,360,139 | 0.0% |
| Cincor Pharma Inc | COM | 17240Y109 | $43.7K | 2,319,117 | 0.0% |
| VBI Vaccines Inc CDA(VAC2USD) | COM NEW | 91822J103 | $42.3K | 52,335,002 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $39.6K | 224,000 | 0.0% |
| Veru Inc(VERUEUR) | COM | 92536C103 | $39.6K | 3,500,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $38.8K | 397,888 | 0.0% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $34.9K | 1,913,791 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $32.5K | 1,943,097 | 0.0% |
| Lilly ELI & Co(LLY) | COM | 532457108 | $32.4K | 100,000 | 0.0% |
| Coherus Biosciences Inc | NOTE 1.500% 4/1 | 19249HAB9 | $29.5K | $4,500,000 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $26.3K | 367,501 | 0.0% |
| Procept Biorobotics Corp(PRCT) | COM | 74276L105 | $24.5K | 749,700 | 0.0% |
| Nautilus Biotechnology Inc(NAUT) | COM | 63909J108 | $24.5K | 9,111,151 | 0.0% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $22.4K | 1,655,007 | 0.0% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $22.1K | 405,759 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $21.9K | 4,132,534 | 0.0% |
| Immatics N.v(IMTX) | SHS | N44445109 | $21.8K | 2,500,000 | 0.0% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $21.7K | 1,914,592 | 0.0% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $20.6K | 1,141,990 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $20.1K | 2,087,956 | 0.0% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $20.1K | 411,804 | 0.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $18.9K | 1,296,416 | 0.0% |